Incannex Healthcare Ltd
ASX:IHL
Incannex Healthcare Ltd
ASX:IHL
Price:
0.041
AUD
Market Cap:
AU$43.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Incannex Healthcare Ltd
ASX:IHL
|
AU |
|
S
|
Superdry PLC
SWB:49S
|
UK |
|
Taiyo Yuden Co Ltd
TSE:6976
|
JP |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
Balance Sheet
Balance Sheet Decomposition
Incannex Healthcare Ltd
Incannex Healthcare Ltd
Balance Sheet Decomposition is not available for
Incannex Healthcare Ltd
Incannex Healthcare Ltd
Balance Sheet
Incannex Healthcare Ltd
Incannex Healthcare Ltd
Currency: AUD
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
0
|
0
|
4
|
9
|
38
|
33
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
33
|
|
| Cash Equivalents |
0
|
0
|
0
|
1
|
0
|
0
|
4
|
9
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
0
|
6
|
0
|
1
|
1
|
0
|
4
|
9
|
38
|
35
|
|
| PP&E Net |
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
53
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
6
-20%
|
0
-94%
|
1
+189%
|
1
-29%
|
1
-27%
|
4
+718%
|
9
+120%
|
38
+306%
|
89
+134%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
6
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
6
N/A
|
6
+1%
|
1
-82%
|
1
+12%
|
1
-7%
|
1
-14%
|
1
+15%
|
1
-30%
|
2
+166%
|
4
+122%
|
|
| Equity | |||||||||||
| Common Stock |
34
|
35
|
0
|
22
|
24
|
27
|
34
|
46
|
87
|
151
|
|
| Retained Earnings |
32
|
34
|
1
|
22
|
25
|
27
|
31
|
37
|
51
|
67
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
0
-77%
|
1
N/A
|
0
+76%
|
0
-127%
|
0
-9%
|
3
N/A
|
9
+171%
|
36
+318%
|
84
+135%
|
|
| Total Liabilities & Equity |
8
N/A
|
6
-20%
|
0
-94%
|
1
+189%
|
1
-29%
|
1
-27%
|
4
+718%
|
9
+120%
|
38
+306%
|
89
+134%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
41
|
69
|
173
|
173
|
316
|
582
|
749
|
1 068
|
1 292
|
1 587
|
|
Switch to:
Switch to:
See Also
Discover More
